Back
Kymera Therapeutics Vs. BioNTech SE Industry Stock Comparison
Buy
54
KYMR
Kymera Therapeutics
Last Price:
48.79
Seasonality Move:
25.63%
Buy
52
BNTX
BioNTech SE
Last Price:
112.39
Seasonality Move:
12.7%
Buy
54
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $46.45. The Score for KYMR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
BioNTech SE (BNTX)
is a Buy
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $115.62. The Score for BNTX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- BNTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $46.45
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing slight selling pressure.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $115.62
The current trend is moderately bullish and BNTX is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 52.28 | Buy |
| Chaikin Money Flow: | -113869 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.73 - 48.29) | Sell |
| Bollinger Bands (100): | (33.25 - 45.35) | Buy |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.77 | Buy |
| Relative Strength Index (14 RSI): | 70.24 | Buy |
| Chaikin Money Flow: | -1842663 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (82.95 - 108.15) | Buy |
| Bollinger Bands (100): | (81.16 - 99.5) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.36 | Buy |
| 20-day SMA: | 47.07 | Sell |
| 50-day SMA: | 44.69 | Buy |
| 200-day SMA: | 36.37 | Buy |
| 8-day EMA: | 46.63 | Sell |
| 20-day EMA: | 46.22 | Buy |
| 50-day EMA: | 43.92 | Buy |
| 200-day EMA: | 36.72 | Buy |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.6 | Buy |
| 20-day SMA: | 97.65 | Buy |
| 50-day SMA: | 89.56 | Buy |
| 200-day SMA: | 93.09 | Buy |
| 8-day EMA: | 112.27 | Buy |
| 20-day EMA: | 101.76 | Buy |
| 50-day EMA: | 93.73 | Buy |
| 200-day EMA: | 94.71 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.72 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.38 per share, and a decrease next year of $0.37 per share.
Kymera Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||